LEN-B
Lennar Corporation
LEN-B trails on the overall score without a compensating advantage in the available component scores.
TSLA
Tesla, Inc.
TSLA has the edge over LEN-B overall, supported by stronger modeled upside and stronger fundamentals.
LEN-B Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
LEN-B's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
LEN-B PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.4x | $28.56 | -65% |
| Fair | 8.2x | $43.53 | -47% |
| Expensive | 11x | $57.92 | -29% |
| Current | 15x | $81.63 | — |
| Forward | 18x | $81.63 | — |
Historical ranges are pointers, not guarantees.
LEN-B has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
LEN-B Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect LEN-B's earnings and profitability to decline, with its revenue holding steady.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over LEN-B on the outlook, with more favorable valuation and earnings expectations.
LEN-B Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.59 | -13% |
| Q3 2026 | $5.28 | -48% |
| Q2 2026 | $6.38 | -47% |
| Q1 2026 | $6.95 | -49% |
| Q4 2025 | $7.98 | -44% |
| Q3 2025 | $10.09 | -33% |
| Q2 2025 | $12.06 | -18% |
| Q1 2025 | $13.70 | -3.8% |
| Q4 2024 | $14.31 | +4.2% |
LEN-B has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
LEN-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8B | -8.7% |
| Q2 2026 | $7.9B | -5.2% |
| Q1 2026 | $6.6B | -13% |
| Q4 2025 | $9.4B | -5.8% |
| Q3 2025 | $8.8B | -6.4% |
| Q2 2025 | $8.4B | -4.4% |
| Q1 2025 | $7.6B | +4.4% |
| Q4 2024 | $9.9B | -9.3% |
LEN-B's revenue has slid since its 2023 peak: $8B last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | -2.2 points |
| Q2 2026 | 5% | -2.5 points |
| Q1 2026 | 3.3% | -5.8 points |
| Q4 2025 | 6.9% | -7.8 points |
| Q3 2025 | 7.9% | -5.7 points |
| Q2 2025 | 7.5% | -6.4 points |
| Q1 2025 | 9.1% | -3.2 points |
| Q4 2024 | 15% | -1.6 points |
LEN-B has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over LEN-B on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
LEN-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$96.3M | +$94.5M |
| Q2 2026 | -$303.2M | +$807M |
| Q1 2026 | -$463.5M | -$118.4M |
| Q4 2025 | $1.7B | +79% |
| Q3 2025 | -$190.8M | -124% |
| Q2 2025 | -$1.1B | -647% |
| Q1 2025 | -$345.1M | -217% |
| Q4 2024 | $933.1M | -63% |
LEN-B's free cash flow has turned positive again: $811M over the past year, against −$713M the year before.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
LEN-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -3M shares |
| 1 year | -7% | -17.8M shares |
| 3 years | -16% | -45.1M shares |
| 5 years | -23% | -69.5M shares |
| Available history | -25% | -80.7M shares |
LEN-B has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $255.9M |
| Q2 2026 | $467.1M |
| Q1 2026 | $269.7M |
| Q4 2025 | $57,000 |
| Q3 2025 | $512.4M |
| Q2 2025 | $521.4M |
| Q1 2025 | $774.5M |
| Q4 2024 | $527.2M |
LEN-B spent $993M buying back its own shares over the past year, down 57% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
LEN-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
LEN-B has more cash than debt.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over LEN-B on leverage, with a lower net debt burden relative to earnings.
LEN-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.1 | Neutral |
| Stochastic | 70.3 | Neutral |
LEN-B's weekly RSI is 46 (neutral) and its Stochastic is 70 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
LEN-B PE vs Consumer Cyclical Sector
| Metric | LEN-B | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 14% below |
| PE % | 99 | 47 | 52 pts above |
LEN-B has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
LEN-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $81.3 | 0.4% above |
| 20 week MA | $82.1 | 0.6% below |
| 50 week MA | $90.3 | 9.6% below |
| 100 week MA | $102.9 | 21% below |
| 200 week MA | $115.3 | 29% below |
LEN-B has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 29% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over LEN-B on trend strength, trading above more of its moving averages.
LEN-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.9 | $64.4 | +44% |
| 2021 | $64.4 | $91.9 | +43% |
| 2022 | $91.9 | $75.1 | -18% |
| 2023 | $75.1 | $134.1 | +78% |
| 2024 | $134.1 | $133.3 | -0.6% |
| 2025 | $133.3 | $97.4 | -27% |
| 2026 YTD | $97.4 | $81.6 | -16% |
LEN-B has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.